Source: CURATED ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs16875288
rs16875288
ADAMTS16 ; LOC101929200
0.700 GeneticVariation GWASCAT Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia. 24039173

2013
dbSNP: rs10405744
rs10405744
ZNF93
A 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs10968749
rs10968749
LINGO2
G 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs11829119
rs11829119
LOC107984527
C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs16935279
rs16935279
LINC01592
C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs17066873
rs17066873 		C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs17154917
rs17154917 		T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs17158930
rs17158930
DOCK4
G 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs17673138
rs17673138
NRG1
C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs17790731
rs17790731
RFESD
A 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs2302045
rs2302045
SNED1 ; MTERF4
T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs6586354
rs6586354 		A 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs9862857
rs9862857
LOC101927995 ; LOC105377013
C 0.700 GeneticVariation GWASCAT Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. 25944848

2015
dbSNP: rs10233018
rs10233018 		A 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs10485715
rs10485715 		C 0.700 GeneticVariation GWASCAT Genome-wide environment interaction between depressive state and stressful life events. 26845276

2016
dbSNP: rs10809520
rs10809520 		T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs10884216
rs10884216
LINC02627
T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs111365677
rs111365677 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs112106319
rs112106319
TNC ; DELEC1
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs112538845
rs112538845 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs11924809
rs11924809
DGKG
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs142484554
rs142484554
SPSB4
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs142641502
rs142641502
CSTF3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs143405544
rs143405544
ADAMTS6
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs143934587
rs143934587 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016